Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by JB Jaroslav Bublevič
Immune Markers in Non-Small Cell Lung Cancer: What Else Beyond Pd-L1 and Tumour Mutational Burden Is There?
Biomedical Journal of Scientific & Technical Research
Related publications
PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Exosomal PD-L1 Promotes Tumor Growth Through Immune Escape in Non-Small Cell Lung Cancer
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Conformance Assessment of PD-L1 Expression Between Primary Tumour and Nodal Metastases in Non-Small-Cell Lung Cancer
OncoTargets and Therapy
Oncology
Pharmacology
PD-1 and PD-L1 Expression in Molecularly Selected Non-Small-Cell Lung Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
P3.09-05 Significance of the Expression of PD-L1/PD-1 by Tumoral and Immune Cells in Non-Small Cell Lung Cancer.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
PD-L1 and Immunotherapy in Patients With Non-Small Cell Lung Cancer and Malignant Pleural Effusion
P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.16-03 Prognostic Significance of PD-L1 in Stage II/III Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated With PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy
Frontiers in Immunology
Allergy
Immunology